• Je něco špatně v tomto záznamu ?

Profile of European proton and carbon ion therapy centers assessed by the EORTC facility questionnaire

DC. Weber, A. Abrunhosa-Branquinho, A. Bolsi, A. Kacperek, R. Dendale, D. Geismar, B. Bachtiary, A. Hall, J. Heufelder, K. Herfarth, J. Debus, M. Amichetti, M. Krause, R. Orecchia, V. Vondracek, J. Thariat, T. Kajdrowicz, K. Nilsson, C. Grau,

. 2017 ; 124 (2) : 185-189. [pub] 20170729

Jazyk angličtina Země Irsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016452

BACKGROUND: We performed a survey using the modified EORTC Facility questionnaire (pFQ) to evaluate the human, technical and organizational resources of particle centers in Europe. MATERIAL AND METHODS: The modified pFQ consisted of 235 questions distributed in 11 sections accessible on line on an EORTC server. Fifteen centers from 8 countries completed the pFQ between May 2015 and December 2015. RESULTS: The average number of patients treated per year and per particle center was 221 (range, 40-557). The majority (66.7%) of centers had pencil beam or raster scanning capability. Four (27%) centers were dedicated to eye treatment only. An increase in the patients-health professional FTE ratio was observed for eye tumor only centers when compared to other centers. All centers treated routinely chordomas/chondrosarcomas, brain tumors and sarcomas but rarely breast cancer. The majority of centers treated pediatric cases with particles. Only a minority of the queried institutions treated non-static targets. CONCLUSIONS: As the number of particle centers coming online will increase, the experience with this treatment modality will rise in Europe. Children can currently be treated in these facilities in a majority of cases. The majority of these centers provide state of the art particle beam therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016452
003      
CZ-PrNML
005      
20180523095924.0
007      
ta
008      
180515s2017 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.radonc.2017.07.012 $2 doi
035    __
$a (PubMed)28764925
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Weber, Damien C $u Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen, Switzerland; RTQA Strategic Committee, EORTC, Brussels, Belgium. Electronic address: damiencharles.weber@uzh.ch.
245    10
$a Profile of European proton and carbon ion therapy centers assessed by the EORTC facility questionnaire / $c DC. Weber, A. Abrunhosa-Branquinho, A. Bolsi, A. Kacperek, R. Dendale, D. Geismar, B. Bachtiary, A. Hall, J. Heufelder, K. Herfarth, J. Debus, M. Amichetti, M. Krause, R. Orecchia, V. Vondracek, J. Thariat, T. Kajdrowicz, K. Nilsson, C. Grau,
520    9_
$a BACKGROUND: We performed a survey using the modified EORTC Facility questionnaire (pFQ) to evaluate the human, technical and organizational resources of particle centers in Europe. MATERIAL AND METHODS: The modified pFQ consisted of 235 questions distributed in 11 sections accessible on line on an EORTC server. Fifteen centers from 8 countries completed the pFQ between May 2015 and December 2015. RESULTS: The average number of patients treated per year and per particle center was 221 (range, 40-557). The majority (66.7%) of centers had pencil beam or raster scanning capability. Four (27%) centers were dedicated to eye treatment only. An increase in the patients-health professional FTE ratio was observed for eye tumor only centers when compared to other centers. All centers treated routinely chordomas/chondrosarcomas, brain tumors and sarcomas but rarely breast cancer. The majority of centers treated pediatric cases with particles. Only a minority of the queried institutions treated non-static targets. CONCLUSIONS: As the number of particle centers coming online will increase, the experience with this treatment modality will rise in Europe. Children can currently be treated in these facilities in a majority of cases. The majority of these centers provide state of the art particle beam therapy.
650    _2
$a nádory kostí $x farmakoterapie $7 D001859
650    _2
$a nádory mozku $x radioterapie $7 D001932
650    _2
$a uhlík $x chemie $x terapeutické užití $7 D002244
650    _2
$a dítě $7 D002648
650    _2
$a chondrosarkom $x radioterapie $7 D002813
650    _2
$a chordom $x radioterapie $7 D002817
650    _2
$a elementární částice $x terapeutické užití $7 D004601
650    _2
$a Evropa $7 D005060
650    _2
$a nádory oka $x radioterapie $7 D005134
650    _2
$a radioterapie těžkými ionty $x přístrojové vybavení $x metody $x statistika a číselné údaje $7 D063193
650    _2
$a lidé $7 D006801
650    _2
$a protonová terapie $x přístrojové vybavení $x metody $x statistika a číselné údaje $7 D061766
650    _2
$a protony $7 D011522
650    _2
$a průzkumy a dotazníky $7 D011795
655    _2
$a časopisecké články $7 D016428
700    1_
$a Abrunhosa-Branquinho, André $u EORTC HQ, Brussels, Belgium.
700    1_
$a Bolsi, Alessandra $u Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen, Switzerland.
700    1_
$a Kacperek, Andrzej $u Eye Proton therapy Centre Clatterbridge Cancer Centre, Bebington, UK.
700    1_
$a Dendale, Rémi $u Protontherapy Center (ICPO), Institut Curie, Paris, France.
700    1_
$a Geismar, Dirk $u Clinic for Particle Therapy, West German Proton Therapy Centre Essen, University Hospital Essen, Germany.
700    1_
$a Bachtiary, Barbara $u Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen, Switzerland; Rinecker Proton Therapy Center, Munich, Germany.
700    1_
$a Hall, Annika $u Skandionklinick, Uppsala, Sweden.
700    1_
$a Heufelder, Jens $u Charité-Universitätsmedizin Berlin, BerlinProtonen am HZB, Germany.
700    1_
$a Herfarth, Klaus $u University of Heidelberg, Germany; University Hospital of Heidelberg, Germany.
700    1_
$a Debus, Jürgen $u University of Heidelberg, Germany; University Hospital of Heidelberg, Germany.
700    1_
$a Amichetti, Maurizio $u Proton Therapy Centre, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.
700    1_
$a Krause, Mechthild $u Department of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden, Germany.
700    1_
$a Orecchia, Roberto $u Scientific Directorate, European Institute of Oncology, Centro Nazionale Adroterapia Oncologica, Milan and Pavia, Italy.
700    1_
$a Vondracek, Vladimir $u Proton Therapy Center, Prague, Czech Republic.
700    1_
$a Thariat, Juliette $u Centre Antoine Lacassagne, University Sophia Antipolis, Nice, France.
700    1_
$a Kajdrowicz, Tomasz $u Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland.
700    1_
$a Nilsson, Kristina $u The Svedberg Laboratory, Uppsala University, Sweden.
700    1_
$a Grau, Cai $u Department of Oncology, Aarhus University Hospital, Denmark.
773    0_
$w MED00004049 $t Radiotherapy and oncology journal of the European Society for Therapeutic Radiology and Oncology $x 1879-0887 $g Roč. 124, č. 2 (2017), s. 185-189
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28764925 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180523100109 $b ABA008
999    __
$a ok $b bmc $g 1300076 $s 1013292
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 124 $c 2 $d 185-189 $e 20170729 $i 1879-0887 $m Radiotherapy and oncology $n Radiother Oncol $x MED00004049
LZP    __
$a Pubmed-20180515
Zpět

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace